4D-NUCLEOFECTOR
LIVE

Serial Number

79083168

Owner

LONZA COLOGNE AG

Attorney

Lawrence J. Crain

Filing Date

Feb 26, 2010

Add to watchlist:

No watchlists yet
View on USPTO

4D-NUCLEOFECTOR Trademark

Serial Number: 79083168 • Registration: 3976607

4D-NUCLEOFECTOR is a trademark filed by LONZA COLOGNE AG on February 26, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

LONZA COLOGNE AG (12 trademarks)

KOELN 50829 , DE

Entity Type: 09

Lonza Cologne GmbH (12 trademarks)

Nattermannallee 1
50829 Köln , DE

Entity Type: 98

Trademark Details

Filing Date

February 26, 2010

Registration Date

June 14, 2011

Published for Opposition

March 29, 2011

Goods & Services

Scientific apparatus and instruments, namely, electric field and voltage pulse generators for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, capacitors, transistors, power semiconductors, electric relays, transformers, electrical conductors and contacts, and electric measuring and controlling instruments, namely, voltmeters, amperemeters and electrical controllers; devices, containers and reaction vessels being laboratory equipment for biochemical purposes, as far as included in this class, for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins, namely, test tubes for laboratory purposes, electrodes made of metal and conductive polymers, cuvettes being laboratory equipment made of synthetic material, cuvettes being laboratory equipment, including those having electrodes made of metal and conductive polymers, for biochemical purposes; containers and reaction vessels being laboratory equipment having several reaction chambers, including those having electrodes made of metal and conductive polymers, for biochemical purposes, and multi-well plates being laboratory equipment, including those having electrodes made of metal and conductive polymers, for biochemical purposes; [ prerecorded magnetic data carriers for use in the field of analysis and control of biochemical processes; prerecorded floppy-disks for use in the field of analysis and control of biochemical processes, prerecorded compact disks for use in the field of analysis and control of biochemical processes, ] prerecorded DVDs for use in the field of analysis and control of biochemical and biophysical processes; data processors and computers; peripheral equipment for computers; computer programs and software, namely, computer software for use in analysing and controlling biochemical and biophysical processes in the field of transferring biological molecules into living cells, integrating foreign nucleic acids into the genome of living cells and transient production of proteins

Pharmaceutical and veterinary preparations for medical and clinical purposes for treating genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary purposes for diagnosis and analysis of genetic defects, viral and infectious diseases, cardiovascular diseases and cancer; living cells, micro-organisms as well as proteins, peptides and nucleic acids or complexes of these molecules for medical and clinical purposes for treating genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer

Chemical and biochemical preparations for industrial and scientific purposes, namely, agents for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; soluble substances and solutions, namely, buffer and standard solutions for industrial and scientific purposes for the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins; aqueous solutions containing nutrients for cultivating living cells for industrial and scientific purposes; biological agents for laboratories, except for medical and veterinary purposes; diagnostics, except for medical and veterinary purposes; peptides, proteins and nucleic acids or complexes of these molecules for industrial and scientific use for detecting and monitoring purposes as well as for integration of foreign nucleic acids into the genome of living cells and transient production of proteins; chemicals in the nature of expression and control vectors for industrial and scientific use; reagents for transfection for transient production of proteins, except for medical and veterinary purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2024 REAP
PARTIAL INVALIDATION PROCESSED BY THE IB
Aug 8, 2022 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 18, 2022 INPS
INVALIDATION PROCESSED
May 18, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 19, 2022 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 19, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
May 19, 2021 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 19, 2021 APRE
TEAS SECTION 71 RECEIVED
Mar 12, 2021 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 14, 2020 REM4
INTERNATIONAL REGISTRATION RENEWED
Mar 12, 2020 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2019 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 24, 2017 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 24, 2017 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 24, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
May 10, 2017 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 14, 2016 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 25, 2013 FINO
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 9, 2013 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 29, 2012 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Aug 3, 2012 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Nov 3, 2011 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2011 FIMP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 31, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 31, 2011 REAP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2011 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 5, 2011 ADCH
PUBLISHED FOR OPPOSITION
Mar 29, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 10, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 10, 2011 OP2R
NOTICE OF PUBLICATION
Mar 9, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 23, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 16, 2011 XAEC
EXAMINERS AMENDMENT MAILED
Feb 16, 2011 CNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 16, 2011 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2011 CRFA
ASSIGNED TO LIE
Jan 19, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2011 TROA
REFUSAL PROCESSED BY IB
Aug 6, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2010 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 13, 2010 RFCR
NON-FINAL ACTION WRITTEN
Jul 12, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 6, 2010 MAFR
ASSIGNED TO EXAMINER
Jun 30, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2010 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Jun 28, 2010 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 25, 2010 REPR